Overview

Transitioning From Cyclosporine to Alefacept in Psoriasis

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to devise a safe and effective method for transitioning patients from cyclosporine to alefacept.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborator:
Biogen
Treatments:
Alefacept
Cyclosporine
Cyclosporins